Results 11 to 20 of about 30 (30)

A prospective study on the efficacy of sequential treatment of technology Lipido‐Colloid Impregnated with Silver and Technology Lipido‐Colloid Nano‐Oligosaccharide Factor in the management of venous leg ulcers

Health Science Reports, 2023
Kai Siang Chan, Enming Yong, Zhiwen Joseph Lo   +2 more
exaly  

The Effectiveness of Using a Lipido-Colloid Dressing for Patients With Traumatic Digital Wounds

Clinical Nursing Research, 2006
Moon Fai Chan
exaly  

Direct Lipido-Metabolomics of Single Floating Cells for Analysis of Circulating Tumor Cells by Live Single-cell Mass Spectrometry

Analytical Sciences, 2015
Sara Amer, Takanori Harada, Yasmine Abouleila   +2 more
exaly  

Optimizing wound care with a new lipido-colloid dressing (Urgotul® Duo)

British Journal of Nursing, 2007
S Meaume, P Meyer, S Bohbot
exaly  

Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract ofSerenoa repens (LSESr, Permixon�) in benign prostatic hyperplasia

Prostate, 2000
Francis Vacherot, Jean-Pierre Raynaud, Dominique K Chopin   +2 more
exaly  

The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia

BJU International, 2004
Glenn S Gerber
exaly  

Lipido‐sterolic extract of Serenoa repens (LSESr, Permixon®) treatment affects human prostate cancer cell membrane organization

Journal of Cellular Physiology, 2009
E Petrangeli, L Lenti, Patrizio Sale
exaly  

Mutations du gène codant pour la protéine matricielle extra-cellulaire 1 dans la lipido-protéinose

Annales De Dermatologie Et De Venereologie, 2004
O Dereure
exaly  

Distribution study of radioactivity in rats after oral administration of the lipido/sterolic extract ofSerenoa repens (Permixon®) supplemented with [1-14C]-lauric acid, [1-14C]-oleic acid or [4-14C]-β-sitosterol

European Journal of Drug Metabolism and Pharmacokinetics, 1997
P Benard
exaly  

The mechanism on which the lipido-sterolic extract of serenoa repens (permixon®) inhibits both isoforms of 5αreductase without interfering with PSA production in the prostate

European Urology Supplements, 2003
Margaret Ross, Fouad K Habib
exaly